These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Hepatitis C and liver fibrosis. Schuppan D; Krebs A; Bauer M; Hahn EG Cell Death Differ; 2003 Jan; 10 Suppl 1():S59-67. PubMed ID: 12655347 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of ALK5 as a new approach to treat liver fibrotic diseases. de Gouville AC; Huet S Drug News Perspect; 2006 Mar; 19(2):85-90. PubMed ID: 16628263 [TBL] [Abstract][Full Text] [Related]
27. Fibrosis in the liver: acute protection and chronic disease. Lee Y; Friedman SL Prog Mol Biol Transl Sci; 2010; 97():151-200. PubMed ID: 21074733 [TBL] [Abstract][Full Text] [Related]
28. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. Kisseleva T; Brenner DA J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S73-8. PubMed ID: 17567473 [TBL] [Abstract][Full Text] [Related]
29. [Liver fibrosis in hepatitis B: a dynamic process]. Bedossa P Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 2():S103-8. PubMed ID: 21095512 [TBL] [Abstract][Full Text] [Related]
30. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Elsharkawy AM; Oakley F; Mann DA Apoptosis; 2005 Oct; 10(5):927-39. PubMed ID: 16151628 [TBL] [Abstract][Full Text] [Related]
31. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598 [TBL] [Abstract][Full Text] [Related]
32. Adipokines and liver fibrosis. Marra F; Aleffi S; Bertolani C; Petrai I; Vizzutti F Eur Rev Med Pharmacol Sci; 2005; 9(5):279-84. PubMed ID: 16231590 [TBL] [Abstract][Full Text] [Related]
33. [Pathogenesis of liver fibrosis: modulation of stellate cells by chemokines]. Wasmuth HE; Weiskirchen R Z Gastroenterol; 2010 Jan; 48(1):38-45. PubMed ID: 20072995 [TBL] [Abstract][Full Text] [Related]
34. Apoptosis and liver fibrosis: antifibrotic strategies. Calès P Biomed Pharmacother; 1998; 52(6):259-63. PubMed ID: 9755825 [TBL] [Abstract][Full Text] [Related]
36. The role of the renin-angiotensin system in liver fibrosis. Munshi MK; Uddin MN; Glaser SS Exp Biol Med (Maywood); 2011 May; 236(5):557-66. PubMed ID: 21508249 [TBL] [Abstract][Full Text] [Related]
37. [Liver fibrosis: pathophysiology, diagnosis and treatment]. Pár A; Pár G Orv Hetil; 2005 Jan; 146(1):3-13. PubMed ID: 15715367 [TBL] [Abstract][Full Text] [Related]
38. Cellular communications and cell-matrix interactions in the pathogenesis of fibroproliferative diseases: liver fibrosis as a paradigm. Gressner AM; Bachem MG Ann Biol Clin (Paris); 1994; 52(3):205-26. PubMed ID: 7998677 [TBL] [Abstract][Full Text] [Related]
39. [Persectives on postgenome medicine: Gene therapy for liver cirrhosis]. Ueki T; Okamoto E; Takeuchi M; Fujimoto J Nihon Rinsho; 2001 Jan; 59(1):152-6. PubMed ID: 11197847 [TBL] [Abstract][Full Text] [Related]
40. Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis. Pinzani M; Gentilini P Semin Liver Dis; 1999; 19(4):397-410. PubMed ID: 10643625 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]